Cargando…
Treatment Strategy for Non-Responders to PDE5 Inhibitors
Currently, phosphodiesterase type 5 (PDE5) inhibitors are the initial treatment option for erectile dysfunction. The reported efficacy of PDE5 inhibitors is about 70%, although it is significantly lower in difficult-to-treat subpopulations. Treatment failures might be due to the severity of the unde...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Sexual Medicine and Andrology
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640150/ https://www.ncbi.nlm.nih.gov/pubmed/23658863 http://dx.doi.org/10.5534/wjmh.2013.31.1.31 |